Ringaskiddy, Ireland
Janssen Sciences Ireland, a subsidiary of Johnson & Johnson, began constructing a $355 million, 206,000-sf pharmaceutical manufacturing facility in October of 2017 in Ringaskiddy. Existing facilities accommodating administration, logistics, and warehousing will also be expanded. Completion is expected in late 2019.
Source
